Gilmore O’Neill

Gilmore O’Neill

Chief Executive Officer chez EDITAS MEDICINE, INC.

Fortune : 2 M $ au 31/03/2024

59 ans
Health Technology
Consumer Services
Commercial Services

Postes actifs de Gilmore O’Neill

SociétésPosteDébutFin
UNITY BIOTECHNOLOGY, INC. Director/Board Member 14/12/2020 -
Independent Dir/Board Member 14/12/2020 -
EDITAS MEDICINE, INC. Director/Board Member 01/06/2022 -
Chief Executive Officer 01/06/2022 -
President 01/06/2022 -
Corporate Officer/Principal - -
Director/Board Member - -

Historique de carrière de Gilmore O’Neill

Anciens postes connus de Gilmore O’Neill

SociétésPosteDébutFin
APTINYX Director/Board Member 19/10/2021 14/04/2023
Independent Dir/Board Member 19/10/2021 14/04/2023
SAREPTA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 07/06/2018 17/11/2021
BIOGEN INC. Chief Tech/Sci/R&D Officer 01/11/2016 01/06/2018
Corporate Officer/Principal 01/04/2003 01/11/2016

Formation de Gilmore O’Neill

Harvard University Graduate Degree
University College Dublin Undergraduate Degree

Statistiques

Internationale

Etats-Unis 9
Irlande 2

Opérationnelle

Director/Board Member 4
Chief Tech/Sci/R&D Officer 2
Corporate Officer/Principal 2

Sectorielle

Health Technology 6
Consumer Services 3
Commercial Services 3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Sociétés cotées5
BIOGEN INC.

Health Technology

SAREPTA THERAPEUTICS, INC.

Health Technology

EDITAS MEDICINE, INC.

Health Technology

APTINYX

Health Technology

UNITY BIOTECHNOLOGY, INC.

Health Technology

Entreprise privées2

Commercial Services

Commercial Services

Voir les connexions sociétés